Treatment of restless leg syndrome with pergolide - an open clinical trial

Movement Disorders

Volumn 13, Issue 3, 1998, Pages 566-569

  Winkelmann, Juliane ^a   Wetter, Thomas C ^a   Stiasny, Karen ^b   Oertel, Wolfgang H ^b   Trenkwalder, Claudia ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Pegolide; Restless leg syndrome; Therapy

Indexed keywords

DOMPERIDONE; LEVODOPA; PERGOLIDE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; HUMAN; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SLEEP DISORDER;

AGED; ANTIPARKINSON AGENTS; DOMPERIDONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PERGOLIDE; RESTLESS LEGS SYNDROME; TREATMENT OUTCOME;

EID: 0031945163     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870130333     Document Type: Article

References (12)

1. Trenkwalder C, Stiasny K, Pollmaecher T, et al. L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial. Sleep 1995;18:681-688.
2. Brodeur C, Montplaisir J, Godbout R, Marinier R. Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study. Neurology 1988;38: 1845-1848.
3. Walters AS, Hening WA, Kavey N, Chokoverty S, Gidro-Frank S. A double-blind randomized crossover trial of bromocriptine. Ann Neurol 1988;24:455-458.
4. Becker PM, Jamieson AO, Brown WD. Dopaminergic agents in restless legs syndrome and periodic limb movements of sleep: response and complications of extended treatment in 49 cases. Sleep 1993;16:713-716.
5. von Scheele C, Kempi V. Long-term effect of dopaminergic drugs in restless legs. Arch Neurol 1990;47:1223-1224.
6. Guilleminault C, Cetel M, Philip P. Dopaminergic treatment of restless legs and rebound phenomenon. Neurology 1993;43:445.
7. Allen RP, Earley CJ. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 1996;19:205-213.
8. Silber MH, Shepard JW, Wisbey JA. The role of pergolide in the management of restless legs syndrome. Sleep Research 1995;24: 366.
9. Lin SC. The effect of pergolide on the treatment of resistant restless legs syndrome. Sleep Research 1995;24:277.
10. Earley CJ, Allen RP. Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients. Sleep 1997;19:801-810.
11. Walters AS, International Restless Legs Syndrome Study Group. Towards a better definition of the restless legs syndrome. Mov Disord 1995;10:634-642.
12. Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lesperace P. Clinical, polysomnographic, and genetic characteristic of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord 1997;12:61-65.